News

DexCom (NasdaqGS:DXCM) Gains FDA Clearance For Dexcom G7 System
DexCom (NasdaqGS:DXCM) recently experienced a 14% price increase over the past week. This uptick coincides with the company's announcement of FDA clearance for the Dexcom G7 Continuous Glucose ...
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
PharmiWeb3d
Factors Driving Expansion in the HbA1c Testing Devices Market
As per Vantage Market Research, the Global Hba1c Testing Device Market has been significantly growing over the years due to ...
Endocrinology Advisor5d
FDA Clears Dexcom G7 15 Day for Continuous Glucose Monitoring
The FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for individuals 18 years and older with ...
HME News5d
Dexcom gets clearance for long-wearing CGM
Dexcom has announced that the U.S. Food and Drug Administration has cleared its G7 15 Day Continuous Glucose Monitoring ...
Tap Into the Silver Economy Boom With These Aging Demographics Stocks
The global demographic shift is reshaping healthcare demand, driving long-term investment in pharmaceuticals, medical devices ...